CA3000494A1 – October 6, 2019 – PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIS, USES THEREOF AND METHODS FOR ALLEVIATING STRESS AND/OR ANXIETY

Please complete the required fields.




Inventors :

NIJHAWAN, PARDEEP - 34 BERNADOTTE DR

Owner :

EXZELL PHARMA INC.

Application Number :

CA3000494

Document Number :

CA3000494A1

Priority Date :

April 6, 2018

Filing Date :

April 6, 2018

Date of Grant/ Publication :

October 6, 2019

Class :

A61K36 / 185; A61K31 / 05; A61K31 / 192; A61K31 / 197; A61K31 / 352; A61K31 / 375; A61K31 / 4415; A61K31 / 455; A61K31 / 51; A61K31 / 519; A61K31 / 525; A61K31 / 714; A61K36 / 53; A61K36 / 81; A61K36 / 87; A61P25 / 22

Abstract

A pharmaceutical composition containing cannabis is provided for treating stress and/or anxiety in a patient. Also provided are a use of the pharmaceutical composition for treating stress and/or anxiety in a patient, and methods for treating stress and/or anxiety. The pharmaceutical composition preferably includes a combination of therapeutically effective amounts of one or more of the following medicinal ingredients: cannabis, an herb, a Vitamin B, and/or Vitamin C.

Claim(s)

claim 1: 1 . A pharmaceutical composition for treating stress and/or anxiety in a patient comprising a therapeutically effective amount of cannabis , an herb, Vitamin B, Vitamin C and pharmaceutically acceptable excipients.;
claim 2: 2 . The pharmaceutical composition of claim 1 , wherein the cannabis is selected from the group consisting of: cannabidiol (CBD), cannabidiol acid (CBDA), cannabinol (CBN), cannabigerol (CBG), cannabigerol acid (CBGA), cannabidivarin (CBDV), cannabidivarin acid (CBDVA), cannabinovarin (CBNV), cannabigerovarin (CBGV), cannabichromene (CBC), a naphthoylindole, a phenylacetylindole, a benzoylindole, a cyclohexylphenole, delta-9 tetrahydrocannabinol (THC or dronabinol), delta-8 tetrahydrocannabinol (D8-THC), tetrahydrocannabinol acid (THCA), tetrahydrocannabivarin (THCV), tetrahydrocannabivarin acid (THCVA), the pharmaceutical agent is CBD, THC or combinations thereof.;
claim 3: 3 . The pharmaceutical composition of claim 2 , wherein the herb is selected from the group consisting of: Lemon balm ( Melissa officinalis ); Passion flower ( Passiflora incarnata ); pomegranate (Punica granatum); grape ( Vitis vinifera ); ashawaganda, Indian Ginseng (Somnifera); and combinations thereof.;
claim 4: 4 . The pharmaceutical composition of claim 3 comprising: Lemon balm ( Melissa officinalis ) from about 5 mg to about 1600 mg per dose; Passion flower ( Passiflora incarnata ) from about 25 mg to about 3000 mg per dose; pomegranate (Punica granatum) from about 2 mg to about 1600 mg per dose; grape ( Vitis vinifera ) from about 1 mg to about 900 mg per dose; and/or ashawaganda, Indian Ginseng (Somnifera) from about 25 mg to about 2000 mg per dose.;
claim 5: 5 . The pharmaceutical composition of claim 3 comprising: Lemon balm ( Melissa officinalis ) from about 15 mg to about 30 mg per dose; Passion flower ( Passiflora incarnata ) from about 50 mg to about 100 mg per dose; pomegranate (Punica granatum) from about 2.5 mg to about 10 mg per dose; grape ( Vitis vinifera ) from about 2.5 mg to about 10 mg per dose; and/or ashawaganda, Indian Ginseng (Somnifera) from about 100 mg to about 200 mg per dose.;
claim 6: 6 . The pharmaceutical composition of claim 5 , wherein vitamin B is selected from the group consisting of: Vitamin B1 (Thiamine); Vitamin B2 (Riboflavin); Vitamin B3 (Niacinamide); Vitamin B5 (Pantothenic Acid); Vitamin B6 (Pyridoxine); Vitamin B9 (Folate); Vitamin B12 (Cobalamin); and combinations thereof.;
claim 7: 7 . The pharmaceutical composition of claim 6 comprising: Vitamin B1 (Thiamine) from about 1 mg to about 50 mg per dose; Vitamin B2 (Riboflavin) from about 1 mg to about 50 mg per dose; Vitamin B3 (Niacinamide) from about 10 mg to about 100 mg per dose; Vitamin B5 (Pantothenic Acid) from about 1 mg to about 50 mg per dose; Vitamin B6 (Pyridoxine) from about 1 mg to about 50 mg per dose; Vitamin B9 (Folate) from about 150 mcg to about 500 mcg per dose; and/or Vitamin B12 (Cobalamin) from about 1 mcg to about 300 mcg per dose.;
claim 8: 8 . The pharmaceutical composition of claim 6 comprising: Vitamin B1 (Thiamine) from about 10 mg to about 30 mg per dose; Vitamin B2 (Riboflavin) from about 10 mg to about 30 mg per dose; Vitamin B3 (Niacinamide) from about 10 mg to about 30 mg per dose; Vitamin B5 (Pantothenic Acid) from about 10 mg to about 30 mg per dose; Vitamin B6 (Pyridoxine) from about 10 mg to about 30 mg per dose; Vitamin B9 (Folate) from about 250 mcg to about 350 mcg per dose; and/or Vitamin B12 (Cobalamin) from about 200 mcg to about 300 mcg per dose.;
claim 9: 9 . The pharmaceutical composition of claim 8 , wherein the vitamin C is from about 50 mg to about 3000 mg per dose.;
claim 10: 10 . The pharmaceutical composition of claim 8 , wherein the vitamin C is from about 200 mg to about 300 mg per dose.;
claim 11: 11 . The pharmaceutical composition of claim 10 , wherein the cannabis comprises from about 1 to about 30 mg of a cannabinoid per dose.;
claim 12: 12 . The pharmaceutical composition of claim 10 , wherein the cannabis comprises from about 2.5 mg to about 10 mg of a cannabinoid per dose.;
claim 13: 13 . Use of a pharmaceutical composition comprising a therapeutically effective amount of cannabis , an herb, Vitamin B, Vitamin C and pharmaceutically acceptable excipients for the treatment of stress and/or anxiety in a patient.;
claim 14: 14 . A method for treating stress and/or anxiety in a patient comprising administering to the patient, in one or more doses, a pharmaceutical composition comprising a therapeutically effective amount of cannabis , an herb, Vitamin B, Vitamin C and pharmaceutically acceptable excipients.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login